MDB Capital Holdings, LLC serves as a foundational platform that finances startups partners with co founders and fosters value creation. The company comprises a group of entities that together act as a unified platform for early stage technology ventures. Its core activities include identifying innovative technologies forming partner companies providing seed capital and guiding them through development intellectual property strategy and financing toward potential public market entry.

Revenue is generated through several channels. Public Ventures earns fees from underwriting and placing securities in micro cap and small cap companies and from its self clearing broker dealer operations. PatentVest charges clients for intellectual property strategy development patent analysis and related legal services. The holding company also gains from equity stakes in partner companies and from successful exits such as initial public offerings mergers or licensing deals.

The company operates through the following segments.

• Public Ventures operates as a growth catalyst that focuses on community driven micro and small cap financings. It is a self clearing broker dealer that provides financing from five million dollars to sixty million dollars to help companies scale and facilitates their transition into public markets with select initial public offerings valued between twenty million and fifty million dollars. It may also provide financing to post IPO companies that meet its investment criteria.

• PatentVest provides integrated intellectual property solutions and acts as a strategic law firm that guides technology companies through intellectual property law and develops IP strategy. It uses a proprietary patent database covering more than one hundred forty eight million patents across one hundred sixteen countries to help clients prioritize inventions enhance protection and make strategic business decisions. The firm is licensed as an Alternative Business Structure in Arizona and offers services such as patent prosecution surveillance and reporting.

• MDB Minnesota One Inc is a partner company created in mid 2024 to develop a small molecule anti senescence platform consisting of pharmaceutical drugs or other products aimed at promoting longevity and inhibiting age related diseases. The platform targets senescent cells that cause chronic low grade inflammation which is linked to fibrotic conditions with limited treatment options. It holds an exclusive license from the Mayo Foundation for Medical Education and Research to develop and commercialize the technology worldwide.

MDB Capital Holdings LLC positions itself as a distinctive participant in the early stage technology investment landscape by combining venture capital functions with broker dealer capabilities and intellectual property services. Its main competitors include traditional venture capital firms funds that focus on micro cap and small cap investments and investment banks that serve those market segments. The company’s competitive advantages stem from its long operating history its reputation for identifying disruptive technologies its network of industry and financial contacts its ability to provide capital at various stages and its experienced team that can source conduct due diligence and manage partner companies through the public venture model.

The company serves early stage technology companies inventors universities and co founders seeking to build businesses around novel technologies. Specific partner companies that have benefited from its platform include Provention Bio Inc Cue BioPharma Inc Pulse Biosciences Inc and eXoZymes Inc formerly known as Invizyne Technologies Inc. Additionally the Mayo Foundation for Medical Education and Research provides licensed technology to MDB Minnesota One. The broader investor base consists of more than five hundred sophisticated investors entrepreneurs and micro cap and small cap market participants who participate through the Public Ventures member community.